161 related articles for article (PubMed ID: 20377880)
21. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
22. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma.
Wang H; Pan K; Zhang HK; Weng DS; Zhou J; Li JJ; Huang W; Song HF; Chen MS; Xia JC
J Cancer Res Clin Oncol; 2008 May; 134(5):535-41. PubMed ID: 17917742
[TBL] [Abstract][Full Text] [Related]
23. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
Khouja MH; Baekelandt M; Nesland JM; Holm R
Int J Gynecol Pathol; 2007 Oct; 26(4):418-25. PubMed ID: 17885492
[TBL] [Abstract][Full Text] [Related]
24. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.
Beà S; Tort F; Pinyol M; Puig X; Hernández L; Hernández S; Fernandez PL; van Lohuizen M; Colomer D; Campo E
Cancer Res; 2001 Mar; 61(6):2409-12. PubMed ID: 11289106
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
Sano T; Masuda N; Oyama T; Nakajima T
Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
[TBL] [Abstract][Full Text] [Related]
26. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Mod Pathol; 2011 Aug; 24(8):1146-55. PubMed ID: 21478826
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
Lin HX; Qiu HJ; Zeng F; Rao HL; Yang GF; Kung HF; Zhu XF; Zeng YX; Cai MY; Xie D
PLoS One; 2013; 8(4):e60516. PubMed ID: 23573264
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.
Wang L; Mao Y; Du G; He C; Han S
Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457
[TBL] [Abstract][Full Text] [Related]
29. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
Tumour Biol; 2014 Oct; 35(10):10259-66. PubMed ID: 25030735
[TBL] [Abstract][Full Text] [Related]
31. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.
Mao TL; Hsu CY; Yen MJ; Gilks B; Sheu JJ; Gabrielson E; Vang R; Cope L; Kurman RJ; Wang TL; Shih IeM
Hum Pathol; 2006 Sep; 37(9):1169-75. PubMed ID: 16938522
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers.
Saeki M; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Int J Oncol; 2009 Sep; 35(3):511-5. PubMed ID: 19639171
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
[TBL] [Abstract][Full Text] [Related]
35. Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins.
Tachibana M; Watanabe J; Matsushima Y; Nishida K; Kobayashi Y; Fujimura M; Shiromizu K
Int J Gynecol Cancer; 2003; 13(5):598-606. PubMed ID: 14675342
[TBL] [Abstract][Full Text] [Related]
36. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Balasubramanian S; Adhikary G; Eckert RL
Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
38. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
39. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J
Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
